|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
JPS5896026A
(ja)
|
1981-10-30 |
1983-06-07 |
Nippon Chemiphar Co Ltd |
新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
|
|
US4609546A
(en)
|
1982-06-24 |
1986-09-02 |
Japan Chemical Research Co., Ltd. |
Long-acting composition
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4606918A
(en)
|
1983-08-22 |
1986-08-19 |
Syntex (U.S.A.) Inc. |
Polyoxypropylene-polyoxyethylene block polymer based adjuvants
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
CA1294215C
(en)
|
1986-10-27 |
1992-01-14 |
Ze'ev Shaked |
Pharmaceutical compositions of recombinant beta-interferon and formulation processes
|
|
CA1292686C
(en)
|
1986-10-27 |
1991-12-03 |
Ze'ev Shaked |
Pharmaceutical compositions of recombinant interleukin-2 and formulation process
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
ATE166578T1
(de)
|
1991-07-25 |
1998-06-15 |
Idec Pharma Corp |
Anregung von antworten zytotoxischer t- lymphozyten
|
|
MA22842A1
(fr)
|
1992-03-27 |
1993-10-01 |
Smithkline Beecham Biolog |
Procede de preparation de compositions de vaccin.
|
|
DE69319728T2
(de)
|
1992-05-23 |
1999-02-04 |
Smithkline Beecham Biologicals S.A., Rixensart |
Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
|
|
CA2138997C
(en)
|
1992-06-25 |
2003-06-03 |
Jean-Paul Prieels |
Vaccine composition containing adjuvants
|
|
SG48309A1
(en)
|
1993-03-23 |
1998-04-17 |
Smithkline Beecham Biolog |
Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
|
|
JP3926839B2
(ja)
|
1993-09-14 |
2007-06-06 |
エピミューン，インコーポレイティド |
万能ｄｒ−結合性ペプチドを用いる免疫応答の改変
|
|
PT992580E
(pt)
|
1993-11-04 |
2005-07-29 |
Innogenetics Nv |
Epitopos para celulas t humanas imunodominantes do virus da hepatite c
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US5709995A
(en)
|
1994-03-17 |
1998-01-20 |
The Scripps Research Institute |
Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
|
|
JPH10503473A
(ja)
|
1994-04-08 |
1998-03-31 |
アメリカ合衆国 |
細胞傷害性ｔリンパ球刺激およびｈｃｖ曝露診断用ｃ型肝炎ウイルスコアペプチド
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
DE69733352T2
(de)
|
1996-03-21 |
2006-04-27 |
Epimmune, Inc., San Diego |
Hla-a2.1 bindende peptide und deren verwendung
|
|
JP3945822B2
(ja)
|
1996-05-24 |
2007-07-18 |
カイロン コーポレイション |
複数エピトープ融合タンパク質
|
|
US6566330B1
(en)
|
1996-10-22 |
2003-05-20 |
Medical University Of South Carolina Foundation Research Development |
Positively charged non-natural amino acids, methods of making and using thereof in peptides
|
|
GB9711990D0
(en)
|
1997-06-11 |
1997-08-06 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
CA2345817C
(en)
|
1998-10-05 |
2013-02-12 |
M&E Biotech A/S |
Novel methods for therapeutic vaccination
|
|
NO311807B1
(no)
*
|
1999-03-04 |
2002-01-28 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
|
|
WO2001021189A1
(en)
|
1999-07-19 |
2001-03-29 |
Epimmune Inc. |
Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
|
|
US20020076415A1
(en)
|
1999-12-14 |
2002-06-20 |
Jing-Hsiung Ou |
Hepatitis C virus gene products
|
|
GB0005703D0
(en)
|
2000-03-09 |
2000-05-03 |
Alpharma As |
Compounds
|
|
WO2002020035A1
(en)
|
2000-09-01 |
2002-03-14 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
NO314587B1
(no)
*
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV
|
|
NO314588B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
|
EP1195381A1
(de)
|
2000-09-28 |
2002-04-10 |
Immusystems GmbH |
CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
|
|
GB0026094D0
(en)
|
2000-10-25 |
2000-12-13 |
Imp College Innovations Ltd |
Methods
|
|
AU2003236728A1
(en)
|
2002-06-10 |
2003-12-22 |
Algonomics N.V. |
Method for predicting the binding affinity of mhc/peptide complexes
|
|
BR0313154A
(pt)
*
|
2002-08-12 |
2005-08-02 |
Council The Queensland Inst Of |
Novos lipopeptìdeos imunogênicos que compreendem epitopos de célula t-helper e de célula b
|
|
WO2004024182A2
(en)
|
2002-09-13 |
2004-03-25 |
Intercell Ag |
Method for isolating hepatitis c virus peptides
|
|
EP1652858A1
(en)
|
2004-10-28 |
2006-05-03 |
Innogenetics N.V. |
Peptides for inducing a CTL and/or HTL response to hepatitis C virus
|
|
MXPA06014065A
(es)
|
2004-06-01 |
2007-01-31 |
Genentech Inc |
Conjugados de droga-anticuerpo y metodos.
|
|
AU2005316844A1
(en)
|
2004-11-29 |
2006-06-22 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
|
US8252893B2
(en)
|
2005-01-31 |
2012-08-28 |
Board Of Trustees Of The University Of Arkansas |
CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
|
|
WO2008107400A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Genimmune N.V. |
Hcv polyepitope construct and uses thereof
|
|
JP5946766B2
(ja)
|
2009-07-03 |
2016-07-06 |
ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ |
Ｈｉｖワクチン組成物における使用又は診断手段としての使用のためのｈｉｖ関連ペプチドの組合せ又は融合物
|
|
CN103282375B
(zh)
|
2010-12-02 |
2017-01-11 |
比奥诺尔免疫有限公司 |
肽支架设计
|
|
AU2012204955B2
(en)
|
2011-01-06 |
2016-10-06 |
Bionor Immuno As |
Monomeric and multimeric immunogenic peptides
|
|
US8618303B2
(en)
*
|
2011-01-07 |
2013-12-31 |
Hoffmann-La Roche Inc. |
Pyrrolidine derivatives
|